Sorry!! The article you are trying to read is not available now.
Gilead Sciences (NQ: GILD)
68.17 USD  +1.38 (+2.07%)
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 15, 2014  /  Add to My Watchlist      
(GILD) Community Analysis from
April 16, 2014
(Jutia Group, 4/15/14)
[Business Wire] - Gilead Sciences, Inc. announced today that its first quarter 2014 financial results will...(read more)
(Jutia Group, 4/11/14)
[Reuters] - Texas is reconsidering whether to impose strict limits on Gilead Sciences' $84,000 hepatitis C treatment for patients on the state's...(read more)
(Stock Blog Hub, 12/14/13)
One of the big winners of Obamacare will be the pharmaceutical industry. Despite new highs for most big pharma companies – they are currently sitting at prices we haven’t seen in a decade –...(read more)
Gilead Sciences (GILD) Company Overview

Gilead Sciences (NYSE: GILD) is a biopharmaceutical company that specializes in the development and commercialization of drugs for the treatment of HIV infection, hepatitis B infection (HBV), cystic fibrosis, fungal infections, and influenza A and B. The company currently produces a market-leading HIV drug portfolio as well as other drugs, which face strong competition from drug-makers such as GlaxoSmithKline (GSK), Novartis AG (NVS), Merck (MRK), Enzon Pharmaceuticals (ENZN), and Bristol-Myers Squibb Company (BMY).In 2010, Gilead generated $7.95 billion in revenues and net earnings of $2.9 billion.[1]

Gilead's profitability can be potentially affected by various factors, including legislative and regulatory changes in federal and private insurance coverage of its drug products, competition from the development of generic drug substitutes, supply shortages of active ingredients in its drugs, the success of clinical trials of newly-developed drugs, and changes in FDA regulations.

(Read more at Wikinvest )

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE